GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » Cyclically Adjusted PS Ratio

Thalys Medical Technology Group (SHSE:603716) Cyclically Adjusted PS Ratio : 1.18 (As of May. 09, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group Cyclically Adjusted PS Ratio?

As of today (2025-05-09), Thalys Medical Technology Group's current share price is ¥10.97. Thalys Medical Technology Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥9.27. Thalys Medical Technology Group's Cyclically Adjusted PS Ratio for today is 1.18.

The historical rank and industry rank for Thalys Medical Technology Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:603716' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.57   Med: 0.79   Max: 1.44
Current: 1.24

During the past years, Thalys Medical Technology Group's highest Cyclically Adjusted PS Ratio was 1.44. The lowest was 0.57. And the median was 0.79.

SHSE:603716's Cyclically Adjusted PS Ratio is ranked better than
68.7% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.08 vs SHSE:603716: 1.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Thalys Medical Technology Group's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥1.405. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥9.27 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Thalys Medical Technology Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Thalys Medical Technology Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group Cyclically Adjusted PS Ratio Chart

Thalys Medical Technology Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.77

Thalys Medical Technology Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.61 0.75 0.77 1.12

Competitive Comparison of Thalys Medical Technology Group's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Cyclically Adjusted PS Ratio falls into.


;
;

Thalys Medical Technology Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Thalys Medical Technology Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=10.97/9.27
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thalys Medical Technology Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Thalys Medical Technology Group's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.405/115.1156*115.1156
=1.405

Current CPI (Mar. 2025) = 115.1156.

Thalys Medical Technology Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.000 99.000 0.000
201509 1.043 100.500 1.195
201512 1.060 100.600 1.213
201603 1.040 102.200 1.171
201606 1.167 101.400 1.325
201609 1.234 102.400 1.387
201612 0.953 102.600 1.069
201703 0.712 103.200 0.794
201706 1.277 103.100 1.426
201709 1.442 104.100 1.595
201712 1.712 104.500 1.886
201803 1.255 105.300 1.372
201806 2.499 104.900 2.742
201809 2.633 106.600 2.843
201812 2.028 106.500 2.192
201903 1.838 107.700 1.965
201906 3.084 107.700 3.296
201909 2.309 109.800 2.421
201912 2.651 111.200 2.744
202003 1.349 112.300 1.383
202006 2.774 110.400 2.892
202009 3.077 111.700 3.171
202012 3.391 111.500 3.501
202103 3.016 112.662 3.082
202106 4.396 111.769 4.528
202109 3.064 112.215 3.143
202112 3.906 113.108 3.975
202203 2.732 114.335 2.751
202206 3.399 114.558 3.416
202209 2.443 115.339 2.438
202212 2.807 115.116 2.807
202303 2.085 115.116 2.085
202306 3.703 114.558 3.721
202309 1.949 115.339 1.945
202312 2.368 114.781 2.375
202403 3.074 115.227 3.071
202406 1.536 114.781 1.540
202409 2.221 115.785 2.208
202412 2.331 114.893 2.336
202503 1.405 115.116 1.405

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Thalys Medical Technology Group  (SHSE:603716) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Thalys Medical Technology Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines